Clinical Trial Update: Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)

View source ↗

Summary

The clinical trial evaluating treatment of Severe Acute Respiratory Syndrome (SARS) sponsored by NIAID has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Severe Acute Respiratory Syndrome | Status: WITHDRAWN